Riskpilot← Back to searchSign inGet full accessTeint AB
ABActiveOrg 5593040362Kista Galleria Trapphus 3 3trRetail sale of medical and orthopaedic goods · NACE 4774Est. 20212 employees
Revenue 2024
SEK 1,6M
+371% vs 2023
EBITDA margin
33.3%
+122% vs 2023
Equity ratio
10.1%
Financial strength
Net profit 2024
SEK 325K
+113% vs 2023
| Revenue | SEK 1,6M | +371% |
| EBITDA | SEK 517K | +122% |
| Net profit | SEK 325K | +113% |
| Total assets | SEK 681K | -37% |
| Equity | SEK 69K | +127% |
| Employees | 2 | — |
Legal name
Teint AB
Org number
5593040362
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
25 februari 2021
Share capital
SEK 28 718
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva sin verksamhet kring farmaceutiska produkter. Bolaget skall även producera samt distribuera produkterna i norden och därmed förenlig verksamhet.
Address
Kista Galleria Trapphus 3 3tr
Email
nebe@teint.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 35 | 581 | 329 | 1 552 |
| Staff expenses | — | −38 | −1 365 | −583 |
| EBITDA | −389 | −68 | −2 299 | 517 |
| Depreciation & amort. | −0 | — | −82 | −85 |
| EBIT | −389 | −68 | −2 380 | 431 |
| Net financials | −5 | −50 | −61 | −107 |
| Profit before tax | −394 | −119 | −2 441 | 325 |
| Tax | −0 | — | — | — |
| Net profit | −394 | −119 | −2 441 | 325 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 371 | 886 | 1 078 | 681 |
| Equity | 103 | −15 | −256 | 69 |
| Long-term debt | 11 | 588 | 1 092 | 325 |
| Short-term debt | 257 | 314 | 242 | 287 |
| Total debt | 268 | 902 | 1 335 | 612 |
EBITDA margin
33.3%
This company
15.8%
Market median
+111% vs market
20212024
Equity ratio
10.1%
This company
38.2%
Market median
-74% vs market
20212024
Return on equity
473.4%
This company
18.4%
Market median
+2473% vs market
20212024
Net profit margin
20.9%
This company
8.1%
Market median
+158% vs market
20212024
Asset turnover
2.28×
This company
1.12×
Market median
+104% vs market
20212024
Debt / equity
8.93×
This company
0.62×
Market median
-1340% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Teint AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Mohammed Yosef Hatem Al-Mayahi | Board of Directors | 0 companies |
| Abozar Ahrabi Kya | Board of Directors | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Nebe Al-Mayahi | Chairman | 0 companies |